Santa Clara, CA, United States of America

Kurt W Scheinpflug

USPTO Granted Patents = 9 

Average Co-Inventor Count = 6.2

ph-index = 6

Forward Citations = 1,353(Granted Patents)


Location History:

  • Santa Clara, CA (US) (2003)
  • Sunnyvale, CA (US) (2002 - 2015)

Company Filing History:


Years Active: 2002-2015

Loading Chart...
9 patents (USPTO):Explore Patents

Title: **Kurt W Scheinpflug: Innovator in Stent Technology**

Introduction

Kurt W Scheinpflug is a prominent inventor based in Santa Clara, CA, renowned for his contributions to the field of medical devices, particularly in stent technology. With a remarkable portfolio consisting of 9 patents, Scheinpflug has made significant advancements that enhance the effectiveness of stents used in medical procedures.

Latest Patents

Scheinpflug's latest patents focus on improving the performance of stents through innovative coating methods. One notable patent, titled "Method of coating a stent with a release polymer for 40-O-(2-hydroxy)ethyl-rapamycin," presents a technique that ensures less than 50% of the total amount of the active agent is released in vivo within a 24-hour period. This method involves modifying the structure of the polymer by exposing the coating to sufficient temperature. Another significant patent is for the "40-O-(2-hydroxy)ethyl-rapamycin coated stent," which outlines a method and coating that effectively reduce the release rate of the active agent from an implantable device, enhancing its therapeutic efficacy.

Career Highlights

Throughout his career, Kurt W Scheinpflug has been associated with Advanced Cardiovascular Systems, Inc., where he has played a crucial role in developing innovative solutions for cardiovascular health. His expertise in stent technology has led to the creation of products that significantly improve patient outcomes.

Collaborations

Scheinpflug has worked alongside talented colleagues such as Syed F A Hossainy and Steven Z Wu, contributing to a collaborative environment that fosters innovation. These partnerships have been instrumental in the successful development and commercialization of advanced medical devices.

Conclusion

In conclusion, Kurt W Scheinpflug's inventive spirit and commitment to enhancing medical technology position him as a key figure in the field of cardiovascular innovations. His patents not only reflect his technical ingenuity but also highlight his dedication to improving patient care through advanced stent technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…